Across the , interest surrounding copyright as a option for psychiatric conditions is surging. While historically viewed primarily as an anesthetic agent, its promise in treating mood disorders, particularly chronic cases, is driving a significant change in clinical practice . However , access remains complex and varies widely within member states,